Kyung Hee University School of Dentistry, Department of Oral Medicine, Hoegi Dong, Dongdaemun Gu, Seoul, Republic of Korea.
Neurosci Lett. 2012 Aug 30;524(2):111-5. doi: 10.1016/j.neulet.2012.07.018. Epub 2012 Jul 20.
Activation of peripheral κ opioid receptors (KOR) effectively relieves pain and hyperalgesia in preclinical and clinical models of pain. Although centrally located KOR activation results in sexually dimorphic effects, it is unclear whether peripheral KOR also produces sex dependent effects in persistent inflammatory pain conditions. In this study, we investigated whether local administration of a specific KOR agonist, U50, 488 relieve mechanical hyperalgesia induced by the injection of complete Freund's adjuvant (CFA) in the rat hindpaw, and whether there are sex differences. The effects of U50, 488 were assessed three days after the induction of CFA-induced inflammation, a time point at which mechanical hyperalgesia was most prominent. There were no sex differences in baseline and CFA-induced changes in mechanical thresholds between male and female rats. Local treatment of U50, 488 produced moderate, but significant, anti-hyperalgesia in both male and female rats. However, U50, 488 was significantly more effective in male rats at the highest dose of U50, 488. We confirmed that the highest dose of U50, 488 used in this study did not produce systemic effects, and that the drug effect is receptor specific. On the basis of these results, we suggest that local KOR agonists are effective in mitigating mechanical hyperalgesia under a persistent inflammatory pain condition and that sex differences in anti-hyperalgesic effects become more evident at high doses.
外周 κ 阿片受体 (KOR) 的激活可有效缓解临床前和临床疼痛模型中的疼痛和痛觉过敏。尽管中枢 KOR 的激活会产生性别二态效应,但外周 KOR 在持续性炎症性疼痛条件下是否也会产生依赖于性别的效应尚不清楚。在这项研究中,我们研究了局部给予特定的 KOR 激动剂 U50,488 是否可以缓解 CFA 注射引起的大鼠后爪机械性痛觉过敏,以及是否存在性别差异。在 CFA 诱导的炎症诱导后三天评估 U50,488 的作用,此时机械性痛觉过敏最为明显。雄性和雌性大鼠的基线和 CFA 诱导的机械阈值变化之间没有性别差异。局部给予 U50,488 可使雄性和雌性大鼠均产生中度但显著的抗痛觉过敏作用。然而,在 U50,488 的最高剂量下,U50,488 在雄性大鼠中的效果更为显著。我们证实,在本研究中使用的 U50,488 的最高剂量不会产生全身效应,并且药物作用是受体特异性的。基于这些结果,我们认为局部 KOR 激动剂可有效减轻持续性炎症性疼痛条件下的机械性痛觉过敏,并且在高剂量下,抗痛觉过敏作用的性别差异变得更加明显。